首页> 外文期刊>The veterinary clinics of North America: small animal practice >Using cardiac biomarkers in veterinary practice. (Special Issue: Clinical pathology and diagnostic testing.)
【24h】

Using cardiac biomarkers in veterinary practice. (Special Issue: Clinical pathology and diagnostic testing.)

机译:在兽医实践中使用心脏生物标志物。 (特刊:临床病理学和诊断测试。)

获取原文
获取原文并翻译 | 示例
           

摘要

Blood-based assays for various cardiac biomarkers can assist in the diagnosis of heart disease in dogs and cats. The two most common markers are cardiac troponin-I and N-terminal pro-B-type natriuretic peptide. Biomarker assays can assist in differentiating cardiac from noncardiac causes of respiratory signs and detection of preclinical cardiomyopathy. Increasingly, studies indicate that cardiac biomarker testing can help assess the risk of morbidity and mortality in animals with heart disease. Usage of cardiac biomarker testing in clinical practice relies on proper patient selection, correct interpretation of test results, and incorporation of biomarker testing into existing diagnostic methods.
机译:各种心脏生物标记物的基于血液的测定法可以帮助诊断猫狗的心脏病。两种最常见的标记是心肌肌钙蛋白I和N端前B型利钠肽。生物标志物测定法可帮助区分心脏和非心脏原因的呼吸道症状和临床前心肌病的检测。越来越多的研究表明,心脏生物标志物检测可以帮助评估患有心脏病的动物发病和死亡的风险。在临床实践中,心脏生物标志物检测的使用取决于对患者的正确选择,对检测结果的正确解释以及将生物标志物检测纳入现有诊断方法中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号